By 2050, over half of the adults and one third of the youth may be obese. Experts have called for urgent action to prevent obesity from becoming the global norm.

“By identifying individuals in a preclinical obesity phase, where they are not yet classified as obese but are showing signs of metabolic dysregulation, there is an opportunity for earlier ...

Join Drs Steven Feldman and Robert Kushner as they discuss the role of dermatologists in treating obesity in conjunction with psoriasis.

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

If the secretary of Health and Human Services truly wants to solve America’s obesity crisis, he must understand that ...

Experts advocate maintaining BMI 25 standard for obesity at Korean health conference Health experts call for adherence to BMI ...

A new screening intervention in the primary care setting can improve the identification and management of obesity risk in pediatric patients, according to a poster presented at the National ...

People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label ...

Research published in Nature determined why obese individuals who lose weight tend to regain the weight over time. Here's how ...

Gastrointestinal adverse events partially mediated the weight loss effects among patients with obesity who received tirzepatide vs placebo.

"Obesity pharmacotherapy ... tirzepatide and lifestyle modification had the lowest mean per-person background healthcare expenditures at $154,028, followed by semaglutide and lifestyle ...